Company Dashboard

Get the latest news, press releases, earnings, outlook, ratings, and dividends for any company.

Biofrontera Inc. ( NASDAQ : BFRI )

Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic

Pre-Market	Intra-Day	After-Hours
1.15 ( -0.02 / -1.71% )	1.16 ( -0.01 / -0.85% )	—
23-Sep 09:19	23-Sep 12:57	22-Sep 19:02

Previous Close	1.17	52-Week Low	0.56
Open	1.17	52-Week High	1.66
Day Low	1.14	50-Day Average	1.30
Day High	1.17	200-Day Average	1.01
Volume	174.76 K	Market Cap	14.85 M

Stock News

Chart

Press Releases

Analysis

Earnings

Outlooks

Ratings

Dividends

Upcoming Catalysts

Press Releases - BFRI

Latest press releases and announcements for BFRI .

Showing 1 – 2 of 2 press releases for BFRI from 2026-08-13 to 2026-09-14

14-Sep-2026 09:26

BFRI

Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma

GlobeNewsWire

Ameluz used in conjunction with the RhodoLED lamp becomes the first and only photodynamic therapy approved in the United States to treat a skin cancer, creating an additional growth opportunity for Biofrontera's photodynamic therapy platform

13-Aug-2026 08:51

BFRI

Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth

GlobeNewsWire

WOBURN, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) in dermatology, today reported financial results for the quarter ended June 30, 2026.